| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 97/06/02 | 100/09/23 | 黃山內 | 鄭志慧 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.74(Q2) | 0 | 5.49 | 0.85% |
| 實收資本額 | 已發行普通股 | ||
| 4,530,108,330 | 453,010,833 | ||
| 主要經營業務 | |||
| 新藥開發 | |||
| 公司網址 | |||
| onenessbio.com | |||
合一(4743) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 6,732 | 4,945 | 13.8% | 36.1% | 54,728 | 1,046,681 | -94.8% |
| 2023/07 | 5,916 | 4,811 | -25.4% | 23% | 47,996 | 1,041,736 | -95.4% |
| 2023/06 | 7,930 | 1,004,296 | 31.5% | -99.2% | 42,080 | 1,036,925 | -95.9% |
| 2023/05 | 6,029 | 5,518 | 1.6% | 9.3% | 34,150 | 32,629 | 4.7% |
| 2023/04 | 5,934 | 7,028 | -49.3% | -15.6% | 28,121 | 27,111 | 3.7% |
| 2023/03 | 11,707 | 8,843 | 109.9% | 32.4% | 22,187 | 20,083 | 10.5% |
| 2023/02 | 5,578 | 5,192 | 13.8% | 7.4% | 10,480 | 11,240 | -6.8% |
| 2023/01 | 4,902 | 6,048 | -22.1% | -18.9% | 4,902 | 6,048 | -18.9% |
| 2022/12 | 6,290 | 5,346 | 49.3% | 17.6% | 1,065,554 | 65,765 | 1520.2% |
| 2022/11 | 4,214 | 5,657 | -1.4% | -25.5% | 1,059,264 | 60,419 | 1653.2% |
| 2022/10 | 4,272 | 7,211 | 4.3% | -40.8% | 1,055,050 | 54,762 | 1826.6% |
| 2022/09 | 4,097 | 6,778 | -17.1% | -39.5% | 1,050,778 | 47,551 | 2109.8% |
| 2022/08 | 4,945 | 8,006 | 2.8% | -38.2% | 1,046,681 | 40,773 | 2467.1% |
| 2022/07 | 4,811 | 9,057 | -99.5% | -46.9% | 1,041,736 | 32,767 | 3079.2% |
| 2022/06 | 1,004,296 | 8,727 | 18100.4% | 11407.9% | 1,036,925 | 23,710 | 4273.4% |
| 2022/05 | 5,518 | 2,281 | -21.5% | 141.9% | 32,629 | 14,983 | 117.8% |
| 2022/04 | 7,028 | 1,721 | -20.5% | 308.4% | 27,111 | 12,702 | 113.4% |
| 2022/03 | 8,843 | 4,559 | 70.3% | 94% | 20,083 | 10,981 | 82.9% |
| 2022/02 | 5,192 | 4,451 | -14.1% | 16.6% | 11,240 | 6,422 | 75% |
| 2022/01 | 6,048 | 1,971 | 13.1% | 206.8% | 6,048 | 1,971 | 206.8% |
| 2021/12 | 5,346 | 2,143 | -5.5% | 149.5% | 65,765 | 41,600 | 58.1% |
| 2021/11 | 5,657 | 700 | -21.5% | 708.1% | 60,419 | 39,457 | 53.1% |
| 2021/10 | 7,211 | 1,914 | 6.4% | 276.8% | 54,762 | 38,757 | 41.3% |
| 2021/09 | 6,778 | 489 | -15.3% | 1286.1% | 47,551 | 36,843 | 29.1% |
| 2021/08 | 8,006 | 52 | -11.6% | 15296.2% | 40,773 | 36,354 | 12.1% |
| 2021/07 | 9,057 | 1,416 | 3.8% | 539.6% | 32,767 | 36,302 | -9.7% |
| 2021/06 | 8,727 | 1,066 | 282.6% | 718.7% | 23,710 | 34,886 | -32% |
| 2021/05 | 2,281 | 2,140 | 32.5% | 6.6% | 14,983 | 33,820 | -55.7% |
| 2021/04 | 1,721 | 28,435 | -62.3% | -93.9% | 12,702 | 31,680 | -59.9% |
| 2021/03 | 4,559 | 1,351 | 2.4% | 237.4% | 10,981 | 3,245 | 238.4% |
| 2021/02 | 4,451 | 1,335 | 125.8% | 233.4% | 6,422 | 1,894 | 239.1% |
| 2021/01 | 1,971 | 559 | -8% | 252.6% | 1,971 | 559 | 252.6% |
| 2020/12 | 2,143 | 1,501 | 206.1% | 42.8% | 41,600 | 13,475 | 208.7% |
| 2020/11 | 700 | 574 | -63.4% | 22% | 39,457 | 11,974 | 229.5% |
| 2020/10 | 1,914 | 300 | 291.4% | 538% | 38,757 | 11,400 | 240% |
| 2020/09 | 489 | 881 | 840.4% | -44.5% | 36,843 | 11,100 | 231.9% |
合一(4743) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | -10.34% | -93.38% | 2020Q3 | -93.81% | -6.60% |
| 2023Q1 | 50.16% | 0.20% | 2020Q2 | 875.07% | 234.96% |
| 2022Q4 | 6.66% | -0.32% | 2020Q1 | 36.63% | -6.97% |
| 2022Q3 | -98.64% | -0.93% | 2019Q4 | -49.79% | -14.51% |
| 2022Q2 | 4963.20% | 1341.20% | 2019Q3 | 116.38% | 3.87% |
| 2022Q1 | 10.26% | 13.84% | 2019Q2 | -47.75% | -3.30% |
| 2021Q4 | -23.60% | 25.73% | 2019Q1 | -10.25% | -16.77% |
| 2021Q3 | 87.30% | 71.93% | 2018Q4 | 12.53% | 23.30% |
| 2021Q2 | 15.92% | -38.33% | 2018Q3 | 53.22% | 31.61% |
| 2021Q1 | 130.84% | 18.60% | 2018Q2 | -63.20% | 22.08% |
| 2020Q4 | 143.08% | 6.07% | 2018Q1 | 568.52% | 267.92% |
評論0